Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
WeightWatchers Rebrands to Capitalize on GLP-1 Popularity - Featured image
Health & Wellness

WeightWatchers Rebrands to Capitalize on GLP-1 Popularity

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·December 17, 2025·3 min read

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

WeightWatchers is undergoing a brand refresh to better integrate GLP-1 medications into its offerings. This shift comes after the company's bankruptcy filing, which cited the rapidly evolving weight management landscape. The rebrand includes new programs and features designed to support members using these medications.

Share

WeightWatchers Rebrands to Capitalize on GLP-1 Popularity

The growing popularity of GLP-1 medications is reshaping the health and wellness sector, potentially offering a crucial boost for WeightWatchers, which filed for bankruptcy last May. The company's bankruptcy announcement highlighted the "rapidly evolving weight management landscape" as a key focus area in its turnaround strategy.

WeightWatchers has previously incorporated GLP-1 options and promoted them in advertisements. However, this comprehensive overhaul positions the booming drug category as a more central and integrated element of its brand identity and business strategy. According to a press release, these changes were inspired by member feedback and are intended to reflect both the brand's 60-year history and a push toward modernization. These adjustments come before the new year, a period when many consumers establish personal fitness objectives, and as the GLP-1 market is projected to exceed $150 billion by 2030, fueled by the success of drugs like Ozempic, Zepbound, and Wegovy. Health tracking apps like Shotlee can help monitor progress and side effects when using such medications.

Julie Rice, chief experience officer at WeightWatchers, stated that this evolution extends beyond a new visual identity. She emphasized that the WeightWatchers brand is embodied in how they present themselves daily through their experience, coaches, community, and medical support. She added that everything is designed around a deep understanding of members' lives and goals, ensuring support feels personal, connected, and consistent across all WeightWatchers interactions.

The identity refresh was led by Mrs&Mr, appointed as WeightWatchers' global brand agency in September. Before bankruptcy and the departure of Oprah as a board member, WeightWatchers had appointed Ogilvy as its global creative agency. Ogilvy's initial campaign, "Fit You," showcased customer testimonials for WeightWatchers' clinical program.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

WeightWatchers has undergone several brand evolutions, including a 2018 rebrand to WW to signal a broader focus on wellness. The most recent update modifies the company's logo, replacing two stacked white Ws within a blue circle with a pair of separated letters bisected by a straight line symbolizing the weight-loss journey. Marketing materials showcase the updated look on various items, such as slippers, socks, and caps, complemented by a rich blue color scheme.

Beyond marketing, WeightWatchers is introducing several new features for its members. These include a dedicated GLP-1 program called Med+, which offers personalized nutrition guidance, medication dose tracking, support for managing drug side effects, and strategies for preserving muscle mass. Additionally, the WeightWatchers digital experience has been updated with an AI body scanner, a new Weight Health Score metric, and premium in-app fitness content for strength and functional movement training.

WeightWatchers has also diversified beyond its traditional focus on points-based weight-loss plans. In September, they launched their first dedicated menopause care program, with Queen Latifah as the celebrity spokesperson.

WeightWatchers, also known as WW International, reported a 10.8% year-over-year decline in total revenues, reaching $172 million for the Q3 period ending Sept. 30, representing their first full quarter post-restructuring. However, revenue from clinical subscriptions showed a positive trend, increasing by 35.3% year-over-year to $26 million.

Source Information

Originally published by Marketing Dive.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: Weight Management

All Weight Management articles →
New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It
Wellness & Health

New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It

New York City is experiencing a surge in peptide therapy requests via telehealth platforms. This article explores the most popular compounds, safety protocols, and how to track results effectively.

8 min read
How Iconic Philly Food Brands Are Adapting to Calorie-Conscious Consumers
Health & Wellness

How Iconic Philly Food Brands Are Adapting to Calorie-Conscious Consumers

Philadelphia's iconic food brands are evolving, introducing high-protein and functional food options to cater to the growing number of calorie-conscious consumers, influenced by trends like GLP-1 medications and a desire for healthier choices.

8 min read
Semaglutide for Weight Loss in Adults Over 65: New Study Findings
Weight Management

Semaglutide for Weight Loss in Adults Over 65: New Study Findings

A recent analysis of the STEP trials reveals that semaglutide, the active ingredient in popular medications like Ozempic and Wegovy, offers significant weight loss and health benefits for adults over 65 with obesity, with a safety profile comparable to younger populations.

8 min read

More in Health & Wellness

Fat Loss with GLP-1s, Muscle Loss Concerns: What Users Need to Know
Health & Wellness

Fat Loss with GLP-1s, Muscle Loss Concerns: What Users Need to Know

GLP-1 medications are powerful tools for weight loss, but concerns are emerging about potential muscle mass loss. This article delves into what users need to know about preserving lean body mass and maintaining cardiorespiratory fitness alongside fat reduction.

7 min read
Jim Cramer on Eli Lilly Amid Rival's GLP-1 Lawsuit
Health & Wellness

Jim Cramer on Eli Lilly Amid Rival's GLP-1 Lawsuit

Jim Cramer weighs in on Eli Lilly's position in the GLP-1 market following a lawsuit from competitor Novo Nordisk, analyzing the situation for investors.

7 min read
GLP-1 Weight-Loss Drugs Linked to Lower Risks of Addiction and Overdose
Health & Wellness

GLP-1 Weight-Loss Drugs Linked to Lower Risks of Addiction and Overdose

Explore the groundbreaking research linking GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Zepbound, to a reduced risk of substance use disorders and fewer addiction-related emergencies.

8 min read
Share this article
  1. Home
  2. Blog
  3. WeightWatchers Rebrands to Capitalize on GLP-1 Popularity
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community